New Educational Initiative, Clinical Trials For All Launches
A new noncommercial, educational campaign, Clinical Trials For All, is being launched to address the lack of awareness around clinical trials that is negatively impacting the health and welfare of people around the world.
“Clinical research isn’t what many people think it is,” said Cinda Orr, founder of SCORR Marketing in a press release. "Patient participation has continued to plague the clinical research industry for too long and research shows that a big reason for this is misunderstanding and awareness. Clinical Trials For All was designed to provide a full range of educational materials from dozens of patients, caregivers, patient advocates, health science organizations, and advocacy groups to help more understand the clinical trial process and how participation might be the right option for you or for a loved one.”
The Clinical Trials For All website consolidates a library of information about clinical trials into one resource and there are ways everyone can join the cause to help increase trial participation and enable greater inclusion in research. Visitors to the website can educate themselves about clinical trials and hear from real patients about their experiences.
Another way to join in the cause is helping spread the word about clinical trials to friends, family, and future patients. The conversation can be joined by using #ClinicalTrialsForAll through Facebook, Instagram, LinkedIn, and X.
Patients, caregivers, patient advocates, health science organizations, and advocacy groups can join Clinical Trials For All as a partner. Current Platinum Partners include Virtue Research and MedVector, as well as a growing list of contributing and participating partners.
Reference
New Educational Initiative, Clinical Trials For All, to Drive More Understanding, Participation, and Diversity. (2023, August 22). Business Wire.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
